These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Animal model of systemic sclerosis. Yamamoto T J Dermatol; 2010 Jan; 37(1):26-41. PubMed ID: 20175838 [TBL] [Abstract][Full Text] [Related]
26. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404 [TBL] [Abstract][Full Text] [Related]
27. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis. Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411 [TBL] [Abstract][Full Text] [Related]
29. Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. Feghali CA; Bost KL; Boulware DW; Levy LS J Rheumatol; 1992 Aug; 19(8):1207-11. PubMed ID: 1404155 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in scleroderma. Feghali CA; Boulware DW; Levy LS J Rheumatol; 1992 Aug; 19(8):1212-9. PubMed ID: 1404156 [TBL] [Abstract][Full Text] [Related]
31. A radical proposal for the pathogenesis of scleroderma. Murrell DF J Am Acad Dermatol; 1993 Jan; 28(1):78-85. PubMed ID: 8425975 [TBL] [Abstract][Full Text] [Related]
32. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma). Nguyen VA; Sgonc R; Dietrich H; Wick G J Autoimmun; 2000 Mar; 14(2):143-9. PubMed ID: 10677245 [TBL] [Abstract][Full Text] [Related]
33. Fibroblast selection in scleroderma. An alternative model of fibrosis. Botstein GR; Sherer GK; Leroy EC Arthritis Rheum; 1982 Feb; 25(2):189-95. PubMed ID: 7066048 [TBL] [Abstract][Full Text] [Related]
34. Lymphatic and blood vessels in scleroderma skin, a morphometric analysis. Rossi A; Sozio F; Sestini P; Renzoni EA; Khan K; Denton CP; Abraham DJ; Weber E Hum Pathol; 2010 Mar; 41(3):366-74. PubMed ID: 20004944 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of collagen production by traditional Chinese herbal medicine in scleroderma fibroblast cultures. Sheng FY; Ohta A; Yamaguchi M Intern Med; 1994 Aug; 33(8):466-71. PubMed ID: 7803912 [TBL] [Abstract][Full Text] [Related]
37. The vascular basement membrane in systemic sclerosis skin: heterogeneity of type IV collagen. Hoyland JA; Newson L; Jayson MI; Freemont AJ Br J Dermatol; 1993 Oct; 129(4):384-8. PubMed ID: 8217749 [TBL] [Abstract][Full Text] [Related]
38. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model. Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693 [TBL] [Abstract][Full Text] [Related]
39. Sequential dermal microvascular and perivascular changes in the development of scleroderma. Prescott RJ; Freemont AJ; Jones CJ; Hoyland J; Fielding P J Pathol; 1992 Mar; 166(3):255-63. PubMed ID: 1517881 [TBL] [Abstract][Full Text] [Related]